In the Know
Find helpful articles, media releases, social media updates, current events, and more.
Recent articles
Texas Children’s Hospital North Austin Campus Set to Op...
Nation’s Largest and Top-Ranked Pediatric and Women’s Hospital Celebrates First Hospital for Central Texas Families with Ribbon Cutting
A MD/PhD student mentored by Dr. Sameer Sheth receives to...
Katherine Kabotyanski recently received prestigious awards from the Society for Neuroscience and Baylor College of Medicine
Dr. Linda Kim receives a prestigious award from the Dysto...
Dr. Linda H. Kim, a postdoctoral fellow in Dr. Roy V. Sillitoe’s lab at Baylor College of Medicine and the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, recently received the Mahlon DeLong Young Investigator Award.
No articles found for awards
No articles found for for physicians
One Team, One Miracle, One Daughter
Leo's Story: Diagnosis and Treatment of congenital heart ...
Helping a young brainstem tumor patient regain control of...
Lifesaving Surgical Care for Patient with HLHS
An innovative machine-learning program reveals genes resp...
Alzheimer's Disease (AD) is a complex neurodegenerative illness with genetic and environmental origins. Females experience faster cognitive decline and cerebral atrophy than males, while males have greater mortality rates.
Distinct types of cerebellar neurons control motor and so...
The cerebellum, a major part of the hindbrain in all vertebrates, is important for motor coordination, language acquisition, and regulating social and emotional behaviors. A study led by Dr. Roy Sillitoe, professor of Pathology and Neuroscience at Baylor College of Medicine and investigator at the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children’s Hospital, shows two distinct types of cerebellar neurons differentially regulate motor and non-motor behaviors during development and in adulthood.
CAR-NKT cell therapy shows promising results against neur...
Researchers at Baylor College of Medicine/Texas Children’s Cancer Center and collaborating institutions report interim results from a first-in-human phase 1 clinical trial evaluating the safety, antitumor activity and immunological characteristics of a genetically engineered natural killer T (NKT) cell immunotherapy for neuroblastoma, a childhood tumor that most commonly arises in the adrenal gland.
Texas Children's Hospital, Baylor College of Medicine nam...
Michael Taylor, MD, PhD, joined Texas Children's Hospital and Baylor College of Medicine as director of the pediatric neuro-oncology research program. The research program will investigate novel therapies for hard-to-treat pediatric brain tumors, including medulloblastoma and ependymoma, according to a Feb. 8 news release from the hospital.